NanoBio Corporation Awarded $70,000 Contract from the U.S. Environmental Protection Agency (EPA)

Strategic Insights -

The U.S. Environmental Protection Agency (EPA) has awarded NanoBio Corporation a six-month contract worth $70,000 to optimize its environmental decontamination product, NanoProtect. This Phase I award is part of the EPA's Small Business Innovation Research Program (SBIR) and has the potential for an additional $225,000 in funding based on the outcome of these studies. The contract aims to develop a safe bio-decontaminant that can kill bacteria, viruses, spores, and fungi without harming humans or the environment. The EPA's interest in NanoProtect is centered around its potential use in the Safe Buildings Program, where it would be used by first responders to decontaminate facilities and equipment in the event of a bio-attack or biohazard accident.

Key Takeaways:

  • NanoBio Corporation has been awarded a $70,000, six-month contract from the EPA's Small Business Innovation Research Program (SBIR) to optimize its environmental decontamination product, NanoProtect.
  • The contract aims to develop a safe bio-decontaminant that can kill bacteria, viruses, spores, and fungi without harming humans or the environment, making it an ideal candidate for the EPA's Safe Buildings Program.
  • The EPA's specific interest in NanoProtect is for its potential use by first responders in the event of a bio-attack or biohazard accident to decontaminate facilities and equipment.
  • The contract has the potential for an additional $225,000 in funding based on the outcome of these studies.
  • NanoBio Corporation is a biopharmaceutical company that has developed a patented antimicrobial nanoemulsion technology, which is the basis for its environmental decontamination product, NanoProtect.
  • The company has received funding from various sources, including sales revenue, investors, the Michigan Life Science Corridor (MLSC) grant, and a grant from the United States Department of Defense, totaling $7.5 million.
  • In addition to NanoProtect, NanoBio Corporation is developing its proprietary NanoStat technology as a pharmaceutical to treat fungal, viral, and bacterial infections of the skin and mucous membranes.
  • The company's products have important therapeutic, safety, and cost advantages over currently available treatments.

Statistics:

  • $70,000: Value of the six-month contract awarded to NanoBio Corporation by the EPA's Small Business Innovation Research Program (SBIR).
  • $225,000: Potential additional funding available to NanoBio Corporation based on the outcome of the Phase I studies.
  • $7.5 million: Total funding received by NanoBio Corporation from various sources, including sales revenue, investors, the Michigan Life Science Corridor (MLSC) grant, and a grant from the United States Department of Defense.

Sources:

  • PRNewswire, "NanoBio Corporation Awarded $70,000 Contract from the U.S. Environmental Protection Agency (EPA)"
  • Company Background: NanoBio Corporation press release
  • EPA's Small Business Innovation Research Program (SBIR) press release
  • Michigan Life Science Corridor (MLSC) press release